million more for prostate research
at the UC Davis Cancer Center this spring received three new grants
totaling more than $1 million to study the genetics of prostate
deVere White, director of the UC Davis Cancer Center, received a
three-year grant of $468,000 from the National Cancer Institute
to study the functions of different p53 mutations in prostate cancer.
P53 is a tumor suppresser gene that plays a key role in many cancers.
Evans, an assistant professor in the Department of Urology, received
a two-year grant of $235,000 from the Department of Defense to study
p53 mutations in archival prostate cancer tissue.
Gumerlock, an assistant professor in the Division of Hematology/Oncology,
received a two-year $425,000 grant from the Department of Defense
to study protein interaction with the N-terminus of the androgen
cancer research at UC Davis receives $2.5 million of the more than
$9 million earmarked for cancer research.
grants bolster the UC Davis Cancer Center's efforts to strengthen
its work in basic research," said deVere White, a professor
and chair of the Department of Urology. "They emphasize that
we are joining the national effort to find better ways to detect,
treat and ultimately cure cancer."
Table of Contents |
To our Readers |
Building on Basics
Focusing on Patients |
In Translation |
Campus Connection |
News in Brief
UC Davis Health System |
© 2000, 2001, 2002 UC Regents. All rights reserved.
Edward Larkin discusses how flow cytometry can be used to diagnose
hematologic malignancies. A professor in the medical school's pathology
department, Larkin was one of more than a dozen presenters and more
than 90 scientists who attended the program.